Elsevier MDL and Fluorochem Partner to Improve Chemical Sourcing
Agreement enhances timely, accurate catalog data in industry-leading MDL® Available Chemicals Directory database
San Ramon, CA and Old Glossop, Derbyshire, UK - April 3, 2007 - Elsevier MDL and Fluorochem, Ltd. are collaborating to help researchers locate and acquire chemical materials with improved ease and reliability.
Under the partnership, Fluorochem provides Elsevier MDL with regular electronic updates of product and pricing information from Fluorochem chemical catalogs. The collaboration facilitates timely updates to the industry-leading MDL® Available Chemicals Directory (MDL ACD) database, which compiles data from suppliers around the world. The partnership also includes a data exchange agreement that simplifies the ordering process for Fluorochem’s chemical materials by referencing the MDL numbers found in the database.
"Our partnership with Elsevier MDL has evolved successfully over many years," said Dr. Martin Woolley, Director of Fluorochem. "The vast majority of our customers use DiscoveryGate® and MDL ACD to source their chemicals, and it is a priority for us to keep our product information and listing as current as possible. We now use MDL numbers in our catalogue and on our website to assist our customers in finding the right chemical. The Elsevier MDL staff is very helpful in providing us with this information. We hope to continue to collaborate closely with them in the future to implement future advances and provide an improving service to our customers."
Fluorochem offers fluorochemicals, silanes, NMR solvents and accessories, inorganics, silica gel and one of the largest ranges of organic intermediates in Europe for chemists who require chemical building blocks for combinatorial chemistry, parallel synthesis and medicinal chemistry needs.
"This collaboration with Fluorochem reflects Elsevier MDL's broad commitment to streamlining the discovery workflow, so scientists can focus on research, not on locating and ordering materials," said Dr. Trevor Heritage, Senior Vice President and Chief Scientific Officer of Elsevier MDL. "By working closely with all our supplier partners, we ensure that electronic chemical catalogs offer the most comprehensive and current information for the benefit of our mutual customers."
The MDL Available Chemicals Directory compiles and indexes detailed product and pricing information for millions of chemical products from hundreds of suppliers. The searchable database is available for in-house installation and is also accessible through the online DiscoveryGate® platform and the MDL® Isentris® system for managing, accessing, analyzing and sharing proprietary and commercial information within scientific workflows. Both systems enable researchers to view chemical sourcing information linked with synthetic methodology, bioactivity, metabolism, toxicity and health and safety content. Researchers can also leverage the value of MDL Available Chemicals Directory through the MDL® Logistics application for sourcing reagents and managing in-house chemical inventories.
Fluorochem is a research chemical catalogue company based in Derbyshire, U.K with over 40 years of experience supplying pharmaceutical companies, universities and research institutes throughout the world with a wide range of products. Their full listing of around 30,000 available products includes fluorochemicals, heterocyclics, boronic acids, sulphur compounds and other novel organics, many unique to Fluorochem. For more information, visit www.fluorochem.net.
About Elsevier MDL
Elsevier MDL provides informatics, database and workflow solutions that accelerate successful scientific R&D by improving the speed and quality of scientists’ decision making. Researchers around the world depend on Elsevier MDL for innovative and reliable discovery informatics software solutions and services augmented by 400 Elsevier chemistry and life sciences journals and related products. For more information, visit www.mdl.com. Elsevier is a world-leading publisher of scientific, technical and medical information products and services. For more information, visit www.elsevier.com. Elsevier is part of Reed Elsevier Group plc, a world-leading publisher and information provider. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange). For more information, visit www.reedelsevier.com.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Phone: +1 925 543-5400
Dr. Martin Woolley
Phone: +44 (0) 1457-868921